17 June 2020 : Clinical Research
Comprehensive Decongestive Therapy as a Treatment for Secondary Lymphedema of the Lower Extremity and Quality of Life of Women After Gynecological Cancer Surgery
Lucia Kendrová1ABCDEFG*, Wioletta Mikuľáková1ABEG, Katarína Urbanová1BEF, Štefánia Andraščíková2CDG, Silvia Žultáková2EFG, Peter Takáč3CDE, Yuriy Peresta1DEFDOI: 10.12659/MSM.924071
Med Sci Monit 2020; 26:e924071
Table 2 Assessment of QoL with LYMQOL.
| Parameters | Treatment | n | Average (SD) | t | P value |
|---|---|---|---|---|---|
| LYMQOL symptoms | Before | 50 | 2.56±0.68 | 5.50 | |
| After | 50 | 2.22±0.57 | |||
| LYMQOL Body image/appearance | Before | 50 | 2.77±0.71 | 4.80 | |
| After | 50 | 2.52±0.65 | |||
| LYMQOL function | Before | 50 | 2.74±0.68 | 5.80 | |
| After | 50 | 2.37±0.76 | |||
| LYMQOL mood | Before | 50 | 1.80±0.61 | 4.99 | |
| After | 50 | 1.56±0.55 | |||
| LYMQOL overall QoL | Before | 50 | 5.62±1.64 | 11.87 | |
| After | 50 | 6.96±1.68 | |||
| VAS | Before | 50 | 5.40±1.98 | 13.62 | |
| After | 50 | 3.56±1.97 | |||
| QoL – quality of life; LYMQOL – Lymphoedema Quality of Life; VAS – Visual Analogue Scale; SD – standard deviation. | |||||